1-4 of 4
Stéphane Giraudier, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

FLT3-Mediated MAPK Activation Participates in the Control of Megakaryopoiesis in Primary Myelofibrosis.

Christophe Desterke, Chrystele Bilhou-Nabera, MD, PhD, Bernadette Guerton, Carole Tonetti, Denis Clay, Olivier Pierre-Louis, Alessandro M Vannucchi, MD, PhD, Heinz Gisslinger, MD, PhD, Dominique Bordessoule, MD, PhD, Hans C Hasselbalch, MD, PhD, Vladimir Lazar, PhD, William Vainchenker, MD, PhD, Annelise Bennaceur-Griscelli, MD, PhD, Stéphane Giraudier, MD, PhD, Marie-Caroline Le Bousse-Kerdilès, PhD
Journal: Blood
Blood (2009) 114 (22): 963.
https://doi.org/10.1182/blood.V114.22.963.963
Published: 2009
Journal Articles

Increased Myelofibrosis in Thrombospondin-1-Null Mice Is Associated with Enhanced TGF-β1-Mediated Response by Bone Marrow Fibroblasts

Solène Evrard, Micheline Tulliez, MD, Eva Zetterberg, MD, PhD, Jan Palmblad, MD, PhD, William Vainchenker, MD, PhD, Jean-Luc Villeval, PhD, Stéphane Giraudier, MD, PhD, Orianne Wagner-Ballon, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 2796.
https://doi.org/10.1182/blood.V112.11.2796.2796
Published: 2008
Journal Articles

Treatment of Myelodysplastic Syndromes with del 5q before the Lenalidomide Era: The GFM Experience.

Charikleia Kelaidi, MD, Sophie Park, MD, Sabine Brechignac, MD, Lionel Mannone, MD, Norbert Vey, MD, Herve Dombret, MD, Lina Aljassem, MD, Aspasia Stamatoullas, MD, Lionel Adès, MD, Stéphane Giraudier, MD, Stéphane de Botton, MD, Béatrice Mahé, MD, Pascale Lepelley, MD, Françoise Picard, MD, Geneviève Leroux, MD, Marie-Thérèse Daniel, MD, Didier Bouscary, MD, François Dreyfus, MD, Pierre Fenaux, MD
Journal: Blood
Blood (2006) 108 (11): 2678.
https://doi.org/10.1182/blood.V108.11.2678.2678
Published: 2006
Journal Articles

P-Loop an T315I BCR-ABL Mutations in Chronic Myelogenous Leukemia (CML) Patients Are of Poor Prognosis, but the Y253H + E255K P-Loop Mutations Are of Even More Severe Prognosis in Chronic Phase. On the Behalf of the French Intergroup of CML (Fi-LMC Group).

Franck E. Nicolini, MD, PhD, Sélim Corm, MD, Quoc-Hung Lê, MD, Sandrine Hayette, PhD, Nathalie Sorel, PhD, Dominique Bories, MD, PhD, Stéphane Giraudier, MD, PhD, Michel Tulliez, MD, Philippe Rousselot, MD, Jean-Michel Cayuela, MD, François-Xavier Mahon, MD, PhD, Pascale Cony-Makhoul, MD, Jean-Jacques Kiladjian, MD, Olivier Tournilhac, MD, François Guilhot, MD, Catherine Roche-Lestienne, PhD, Claude Preudhomme, MD, PhD, Mauricette Michallet, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 3284.
https://doi.org/10.1182/blood.V106.11.3284.3284
Published: 2005